{"entity":{"id":"nct06336148","kind":"trial","name":"A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors","aka":[],"tldr":"A phase 1 trial of ACTM-838 run by Actym Therapeutics, Inc., terminated.","summary":"A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors is a phase 1 interventional study registered as NCT06336148 by Actym Therapeutics, Inc., with 10 participants enrolled, started 2024-06-05. Conditions recorded: Solid Tumor. Interventions recorded: ACTM-838.","status":"historic","asOf":"2026-11-03","links":[{"label":"ClinicalTrials.gov NCT06336148","url":"https://clinicaltrials.gov/study/NCT06336148"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":["actm-838"],"companies":["actym-therapeutics"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06336148","phase":"1","setting":"A Phase 1a/1b Open-label, Dose-Escalation and Expansion Study of ACTM-838 as a Single Agent in Patients With Advanced Solid Tumors","sponsor":"Actym Therapeutics, Inc.","enrolled":10,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06336148/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}],"drug":[{"id":"actm-838","kind":"drug","name":"ACTM-838","route":"/drugs/actm-838/"}],"company":[{"id":"actym-therapeutics","kind":"company","name":"Actym Therapeutics","route":"/companies/actym-therapeutics/"}]}}